Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OXYDOPA trial in central neuropathic pain associated with Parkinson's disease
2015-001523-24Phase 2Terminated
- Sponsor
- Centre hospitalier universitaire de Toulouse
- Start
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of oxycodone in central neuropathic pain (CNP) and Parkinson's disease (PD) (3 arms), sponsored by Centre hospitalier universitaire de Toulouse. Started Apr 2016; status: terminated.
02
Drugs
oxycodone
03
Conditions
central neuropathic pain (CNP)Parkinson's disease (PD)
Beyond the preview
Go deeper on 2015-001523-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-001523-24.